Evaluation of the Clinical Impact of Point-of-Care HIV Early Infant Diagnostic Technologies
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,752
- 试验地点
- 7
- 主要终点
- ART initiation retention
研究概览
简要总结
In Malawi, early infant HIV diagnosis (EID, i.e. HIV screening of infants under 18 months of age) is conducted using molecular diagnostics at central laboratories. However, test volumes are growing and many parts of the country do not have close or easy access to laboratories. Test samples are transported over large distances and this can introduce testing delays, especially for patients in rural and remote areas of the country. There are growing numbers of high quality Point-Of-Care (POC) diagnostic technologies available and there is increasing interest in using these technologies to alleviate critical testing needs. This protocol describes an observational study looking at the patient impact of implementing POC EID technologies within the routine standard of care at seven facilities.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- — 至 12 Months(Child)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Younger than 12 months of age
- •Clinical or other indication for an EID test (screen or confirmation), such as birth to an HIV-positive mother
排除标准
- •Older than 12 months of age
- •Serious medical conditions which would make testing dangerous for the infant, or disrupt the accuracy of normal laboratory analysis and its interpretation
- •Already initiated ART
结局指标
主要结局
ART initiation retention
时间窗: 6-9 months
Proportion of HIV-positive infants initiated on anti-retroviral therapy
次要结局
- Test turnaround time(6-9 months)
- Tests received(6-9 months)
